Core Viewpoint - Baomo Co., Ltd. (002476) has announced plans to utilize idle funds for low-risk financial products and government bond reverse repurchase agreements, aiming to enhance capital efficiency while ensuring operational safety [1]. Group 1: Stock Performance - As of December 29, 2025, Baomo's stock closed at 7.11 yuan, marking a 5.96% increase from the previous trading day [1]. - The stock opened at 6.84 yuan, reached a high of 7.21 yuan, and a low of 6.83 yuan, with a trading volume of 3.74 billion yuan and a turnover rate of 8.65% [1]. Group 2: Financial Strategy - The company’s board of directors approved a proposal to invest up to 50 million yuan of idle self-owned funds in government bond reverse repurchase agreements and low-risk financial products with high liquidity [1]. - The investment will be authorized for a period of 12 months from the date of board approval, allowing for the funds to be recycled within the specified limit [1].

Group 1: New Companies Listed - A total of 10 new companies were listed, with an average revenue of 732 million and a median of 699 million; the average net profit was 47.53 million, with a median of 40.94 million. Notable companies include Yaxun Zhiliang, Qingwa Pump Industry, and Yinuo Biotech [4][16][19] - Yaxun Zhiliang (874947.NQ) is a full-stack integrated vehicle networking software and component supplier, with expected revenue of 801 million and a net profit of 42.03 million in 2024. The company holds 463 domestic and 10 foreign invention patents [4][5][17] - Qingwa Pump Industry (874926.NQ) is recognized as an "invisible champion" in the well submersible pump sector, with a revenue of 537 million and a net profit of 104 million in 2024. The company has ranked first in national sales for six consecutive years from 2019 to 2024 [4][36] - Yinuo Biotech (875019.NQ) specializes in bio-based furan and polyol, with expected revenue of 945 million and a net profit of 104 million in 2024. The company is expanding its applications into various sectors including aerospace and high-end electronic materials [5][19] Group 2: Market Data and Trends - As of December 28, 2025, there are 5,956 companies listed on the New Third Board, with 2,295 in the innovation layer and 3,661 in the basic layer. The number of listed companies has decreased to below 6,000 [3][6] - The total market capitalization of listed companies reached 24,194.71 billion as of November 2025, with a total transaction amount of 53.09 billion in November 2025 and an annual total of 574.17 billion [6][39] - The market for stainless steel well submersible pumps is projected to grow from 2.01 billion in 2018 to 5.55 billion by 2028, with a CAGR of 10.69%. The penetration rate of stainless steel pumps is expected to increase from 27.8% in 2018 to 41.1% by 2028 [42][46] Group 3: Company Innovations and Competitive Landscape - Yaxun Zhiliang has established a strong R&D foundation with 487 technical personnel and has participated in the formulation of 11 national standards and 6 industry standards. The company has received multiple national honors, enhancing its competitive edge [21][30] - Qingwa Pump Industry has developed a comprehensive product system with over 500 models, focusing on energy efficiency and environmental protection. The company is positioned to replace traditional cast iron pumps with its stainless steel products due to their superior characteristics [40][45] - The competitive landscape in the well submersible pump market includes both specialized companies like Qingwa and multi-category pump manufacturers. The market is characterized by a mix of small-scale enterprises and larger firms with diverse product lines [45][46]

Core Viewpoint - The article highlights a significant breakthrough in the biosynthesis of medium-chain fatty acids (MCFAs) by a research team led by Professor Wang Dan from Chongqing University, utilizing engineered Escherichia coli and bamboo waste as a substrate, achieving a production yield of 9.05 g/L in a 5 L fermentation tank [2][5]. Group 1: Research Breakthroughs - The research team constructed an efficient synthesis pathway in E. coli by deleting specific genes to block β-oxidation and enhance the utilization of multiple carbon sources, resulting in an initial MCFA yield of 2.29 g/L [4]. - Further enhancements were made using protein engineering techniques, achieving a yield of 5.83 g/L and the first synthesis of C6 fatty acids [4]. - The introduction of a carbonic anhydrase gene from Anabaena sp. 7120 improved CO₂ conversion efficiency, raising the yield to 6.72 g/L, and subsequent overexpression of a fatty acid regulatory factor led to a final yield of 9.05 g/L [5]. Group 2: Economic and Environmental Impact - The economic analysis indicates that using bamboo waste hydrolysate instead of glucose as a carbon source reduces the production cost of MCFAs by approximately 17% per ton, showcasing both economic and environmental advantages of this biosynthetic route [5]. Group 3: Institutional Background - Chongqing University is a key national research university, actively contributing to regional and industrial development, with significant achievements in research funding and project approvals [7][8]. - The university's chemical engineering and technology programs rank highly globally, reflecting its strong academic capabilities and commitment to innovation in fields like bio-manufacturing [8]. Group 4: Research Team and Leadership - Professor Wang Dan leads the research team, focusing on biosynthesis of chemical products and new materials, with numerous publications in high-impact journals and significant contributions to national research projects [9].

Core Viewpoint - The article highlights the remarkable journey of Zhao Yan, the chairwoman of Huaxi Biological, who transformed the company into a leading player in the hyaluronic acid market and successfully launched popular products like the Palace Museum-themed lipsticks, showcasing her business acumen and resilience [1][19]. Company Overview - Huaxi Biological went public on the Sci-Tech Innovation Board in November 2019, raising a total of 2.3 billion yuan by issuing 49.56 million new shares, indicating strong capital strength and rapid expansion [3]. - The company is recognized as the largest producer of hyaluronic acid raw materials globally, holding a 36% market share in this sector as of its Hong Kong listing [18]. Product Development - The Palace Museum-themed lipsticks launched in 2018 became a hot-selling product, leading to stock shortages on e-commerce platforms, and significantly increased consumer interest in Huaxi Biological [1]. - The lipsticks were well-received, contributing to the company's successful re-listing on the Sci-Tech Innovation Board, where the closing price on the first day rose approximately 78% from the issue price [19]. Leadership and Strategy - Zhao Yan's leadership has been pivotal in Huaxi Biological's success, with her strategic decisions leading to the company's turnaround and market leadership in the beauty sector [16]. - Under her guidance, the company underwent privatization in 2017 to optimize its organizational structure and product strategy, enhancing its competitive edge [18]. Historical Context - Zhao Yan's entrepreneurial journey began in the early 1990s, where she identified business opportunities in various sectors, including real estate and manufacturing, before focusing on the biopharmaceutical industry [7][10]. - The establishment of Huaxi Biological was a result of her collaboration with the Shandong Pharmaceutical Research Institute, where she recognized the potential of hyaluronic acid in the beauty market [13].

Core Viewpoint - The bio-based 1,3-propanediol (PDO) industry in China is transitioning from "technology validation" to "scale production" by 2025, driven by the demand for green transformation in downstream markets such as textiles and cosmetics [2]. Group 1: PDO Production Capacity and Technological Advances - By 2025, multiple companies are accelerating the construction of large-scale production bases for bio-based PDO, with significant investments and technological breakthroughs [4][5]. - Companies like Qingda Zhixing and Heng Carbon Technology have successfully developed fermentation methods for PDO production, breaking the technological monopoly of foreign firms [5][6]. - Heng Carbon Technology has established a unique production base with an annual capacity of 15,000 tons, utilizing a revolutionary "three non-four no" technology that is highly environmentally friendly [6][7]. Group 2: Market Expansion and Applications - PDO is widely applicable in various industries, including polyester, cosmetics, polyurethane, pharmaceuticals, and coatings [10]. - The global bio-based PTT market, which utilizes PDO as a core monomer, is projected to grow from approximately 3.4 billion yuan in 2023 to 8.3 billion yuan by 2030, with a compound annual growth rate of 13.1% [13]. - Companies are forming strategic partnerships to create integrated industrial bases that enhance competitiveness in the bio-based PTT market [13][14]. Group 3: Emerging Companies and Innovations - New companies are emerging with innovative production techniques, such as Shandong Xiangchi Jianyuan Biotechnology, which is implementing advanced fermentation methods to enhance production efficiency [9]. - Zhongke Baiyijin has successfully produced bio-based PDO with a purity of 99.9% using biomass as a raw material [9]. - The industry is witnessing a structural expansion in downstream markets, particularly in textiles and cosmetics, benefiting from reduced raw material costs and increased production capacity [14].

天眼查App显示，近日，九尖蕲艾（深圳）科技有限公司成立，法定代表人为林镇鹏，注册资本10万人 民币，经营范围为一般经营项目是：生物化工产品技术研发；组织文化艺术交流活动；健康咨询服务 （不含诊疗服务）；养生保健服务（非医疗）；日用品批发；日用品销售；化妆品批发；化妆品零售； 品牌管理；电子产品销售；食品销售（仅销售预包装食品）；食品互联网销售（仅销售预包装食品）； 农副产品销售；食用农产品初加工；教育咨询服务（不含涉许可审批的教育培训活动）；招生辅助服 务；业务培训（不含教育培训、职业技能培训等需取得许可的培训）；技术服务、技术开发、技术咨 询、技术交流、技术转让、技术推广。（除依法须经批准的项目外，凭营业执照依法自主开展经营活 动），许可经营项目是：无。 ...

天眼查App显示，近日，南京溧臣生物科技有限公司成立，法定代表人为张义红，注册资本50万人民 币，经营范围为一般项目：生物化工产品技术研发；新材料技术研发；日用化学产品制造；专用化学产 品制造（不含危险化学品）；日用杂品制造；厨具卫具及日用杂品研发；日用品销售；日用百货销售； 日用化学产品销售；消毒剂销售（不含危险化学品）；传统香料制品经营；卫生用杀虫剂销售；卫生用 品和一次性使用医疗用品销售；个人卫生用品销售；普通货物仓储服务（不含危险化学品等需许可审批 的项目）；运输货物打包服务；装卸搬运；化妆品零售；专用化学产品销售（不含危险化学品）（除依 法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - The announcement indicates that Jiangsu Lanfeng Biochemical Co., Ltd., a subsidiary of Lanfeng Biochemical, will receive a capital increase of 30 million yuan from one of its original shareholders, Yuanjiang Bide Chemical Co., Ltd. [1] Group 1 - The capital increase consists of 3 million yuan added to registered capital and 27 million yuan added to capital reserves [1] - Other original shareholders of Lanfeng Biochemical plan to waive their preemptive rights to the capital increase [1] - After the capital increase, the registered capital of Lanfeng Biochemical will rise from 130 million yuan to 133 million yuan, and the company's ownership stake in Lanfeng Biochemical will decrease from 76.92% to 75.19% [1]

天眼查App显示，近日，宿迁迈睿琳生物科技有限公司成立，法定代表人为李浩，注册资本100万人民 币，经营范围为一般项目：生物化工产品技术研发；化妆品零售；日用百货销售；服装服饰零售；工艺 美术品及礼仪用品销售（象牙及其制品除外）；电子产品销售；日用化学产品销售；化妆品批发；个人 卫生用品销售；日用杂品销售；互联网销售（除销售需要许可的商品）（除依法须经批准的项目外，凭 营业执照依法自主开展经营活动）。 ...

天眼查App显示，近日，广东竞取生物科技有限公司成立，注册资本500万人民币，经营范围为一般项 目：生物化工产品技术研发；日用化学产品制造；技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广；化工产品生产（不含许可类化工产品）；化妆品批发；化工产品销售（不含许可类化工 产品）；品牌管理；专用化学产品制造（不含危险化学品）；专用化学产品销售（不含危险化学品）； 日用化工专用设备制造；日用化学产品销售；食品用洗涤剂销售；国内贸易代理；贸易经纪；网络技术 服务；信息技术咨询服务；日用百货销售；日用品销售；包装服务；家居用品制造；广告发布；广告制 作；广告设计、代理；卫生用品和一次性使用医疗用品销售；个人卫生用品销售；消毒剂销售（不含危 险化学品）；互联网销售（除销售需要许可的商品）；进出口代理；货物进出口；技术进出口。（除依 法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：卫生用品和一次性使用医疗用品 生产；消毒剂生产（不含危险化学品）。（依法须经批准的项目，经相关部门批准后方可开展经营活 动，具体经营项目以相关部门批准文件或许可证件为准）。 ...